Clinical Trial Update: Assessing Optimal XRB Initiation Points in Jail [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating optimal initiation points of XRB in jailed individuals with opioid use disorder; sponsor NYU Langone Health is recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• XRB

Snippet

Sponsor: NYU Langone Health | Conditions: Opioid Use Disorder | Phase 4 | Status: RECRUITING